NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 312 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $477,000 | +31.0% | 6,284 | +42.9% | 0.04% | +63.0% |
| Q1 2022 | $364,000 | +0.8% | 4,399 | -8.5% | 0.03% | -27.0% |
| Q4 2021 | $361,000 | -72.2% | 4,808 | -17.8% | 0.04% | -70.6% |
| Q2 2021 | $1,297,000 | +197.5% | 5,846 | +77.2% | 0.13% | +306.5% |
| Q1 2021 | $436,000 | -21.9% | 3,299 | -34.2% | 0.03% | -67.7% |
| Q3 2020 | $558,000 | -56.4% | 5,013 | -75.2% | 0.10% | +28.0% |
| Q2 2019 | $1,280,000 | – | 20,245 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |